Real-World Evidence is essential for demonstrating the long-term safety, efficacy, and value of therapies.
Service features
GCI helps sponsors generate RWE through observational studies, patient registries, and health economics research to support regulatory submissions, market access, and post-marketing commitments.
Observational & Pragmatic Studies
Assessing treatment outcomes in real-world settings.
Patient Registries
Longitudinal data collection for rare and chronic conditions.
Advanced Analytics
AI/ML-powered analytics for deeper insights into treatment effectiveness.
Warranty & Maintance
Our quick time and proactive approach assist our clients to rehearse the future.
Problems we solve
- Lack of post-approval evidence for regulatory and payer requirements
- Limited understanding of real-world treatment outcomes
- Challenges in accessing and analyzing large-scale health data
Popular questions
Why is RWE important after a therapy is approved?
RWE demonstrates how therapies perform outside controlled clinical trials, influencing payer decisions and market adoption.
Does GCI handle both data collection and analytics?
Yes, we provide end-to-end RWE solutions, from data collection to advanced analytics and reporting.
Can RWE support label expansion?
Absolutely. RWE can provide evidence to support additional indications and expanded patient populations.
